Clinical Trials
All Clinical Trials - Page 25 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05291325N/ACompleted
Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy
Linaclotide
- NCT04760782Phase 2Terminated
PTH Analog Type II Odontoid Fracture
Abaloparatide
- NCT05364944Phase 1Terminated
A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Octreotide
- NCT05341089Phase 1Completed
A Study of Two Different Formulations of LY3502970 in Healthy Participants
Orforglipron
- NCT05369390Phase 1Completed
A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity
Amycretin
- NCT05147896N/AUnknown
Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
Semaglutide
- NCT06820047N/ACompleted
Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study
Semaglutide
- NCT05328843Phase 1Unknown
Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function
Exenatide
- NCT05307042N/AUnknown
Decline in Renal Concentration Ability in Lithium Treated Patients
Desmopressin
- NCT05162768Phase 3Completed
Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)
Elamipretide
- NCT03940807Phase 3Withdrawn
Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis
Gonadorelin
- NCT05296733Phase 1Completed
A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906
Survodutide
- NCT05361668Phase 2Completed
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Octreotide
- NCT05221229N/AActive Not Recruiting
Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
Liraglutide
- NCT05260021Phase 3Completed
A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
Tirzepatide
- NCT05071898Phase 1Recruiting
Pharmacogenetics of Response to GLP1R Agonists
Semaglutide
- NCT05370235Phase 2Unknown
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V
Afamelanotide
- NCT05477576Phase 3Active Not Recruiting
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
Octreotide
- NCT04763564Phase 2Terminated
Efficacy of Liraglutide Therapy in Patients With IPAA
Liraglutide
- NCT05151484Phase 4Active Not Recruiting
Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
Teriparatide
- NCT05553093Phase 4Recruiting
Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
Tirzepatide
- NCT04873245Phase 2Completed
Lifestyle Counseling and Medication for Adolescent Weight Management
Semaglutide
- NCT05254418Phase 2Completed
Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
Dulaglutide
- NCT05662189N/ARecruiting
Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus
Exenatide
- NCT05249881EARLY_Phase 1Unknown
"Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."
Semaglutide
- NCT04862143Phase 2Terminated
Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant
Gonadorelin
- NCT04966741Phase 3Completed
Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity
Setmelanotide
- NCT05168774Phase 1/Phase 2Completed
FRDA Investigator Initiated Study (IIS) With Elamipretide
Elamipretide
- NCT06301191N/AUnknown
The Effect of Semaglutide on Cardiovascular Markers and Liver Function
Semaglutide
- NCT07539584N/ACompleted
Adiponectin in Patients With Metabolic Disorders
Semaglutide
- NCT05122377N/ACompleted
RWE About QOL and Compliance of Patients With OFS in China
Gonadorelin
- NCT05131893N/ANot Yet Recruiting
Neoadjuvant Treatment of Breast Cancer
Gonadorelin
- NCT05253066Phase 2/Phase 3Unknown
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer
Gonadorelin
- NCT05199714N/ACompleted
A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes
Pramlintide
- NCT05164614Phase 1Completed
Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule
Teriparatide
- NCT05054361N/ARecruiting
Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children
Ll-37
- NCT05251207N/ACompleted
Plasma Trimethylamine N-oxide Elevation Induced by L-carnitine Supplementation and Insulin Resistance
Dsip
- NCT05227196Phase 1Completed
A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People
Semaglutide
- NCT05136287N/ACompleted
SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.
Semaglutide
- NCT05774119N/ACompleted
Effect of Coffee Consumption on Appetite Traits in Overweight and Obesity
Ghrp-6
- NCT05218915Phase 4Completed
Basal Plus GLP1-ra on Glycemic Variability in CKD
Dulaglutide
- NCT05078255N/ACompleted
The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetes
Semaglutide
- NCT04894188N/ARecruiting
Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer
Gonadorelin
- NCT05268627N/AUnknown
Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
Liraglutide
- NCT05114590Phase 4Completed
Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus
Lixisenatide
- NCT04883606N/ACompleted
A Study With Teduglutide (Revestive®) in Adults With Short Bowl Syndrome
Teduglutide
- NCT04487925Phase 4Unknown
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
Gonadorelin
- NCT05368857Phase 1Completed
DNA Repair Capacity of Afamelanotide on Ultraviolet Radiation-induced DNA Damage in Healthy Volunteers
Afamelanotide
- NCT04307797Phase 4Completed
Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes
Exenatide
- NCT06229899N/ACompleted
Follistatin Levels in Metabolically Healthy and Unhealthy Obese Individuals
Follistatin